Buck Alison, Wang Tao, Baig Sheharyar S, Majid Arshad, Ali Ali N
MRes, Sheffield Teaching Hospitals NHS Foundation Trust, University of Sheffield, Sheffield, UK.
Department of Neuroscience, Sheffield Institute for Translational Neurosciences, University of Sheffield, Sheffield, UK.
J Orthop Surg Res. 2025 May 7;20(1):448. doi: 10.1186/s13018-025-05772-6.
Remote ischaemic conditioning (RIC) involves the use of controlled and transient ischemia and reperfusion cycles, commonly of the upper or lower limb, to mitigate cellular damage from ischaemic events. Studies have demonstrated that RIC may have anti-inflammatory and cardiovascular protective effects and thus could represent a novel therapeutic strategy to improve outcomes following orthopaedic surgery. This review aimed to comprehensively describe the current pre-clinical and clinical evidence for RIC in orthopaedics.
MEDLINE and EMBASE via OVID (1966-March 2024) were searched using a systematic search strategy for randomised controlled trials (RCTs) investigating the effects of RIC on fracture, bone healing, and orthopaedics. Both pre-clinical and clinical RCTs were included.
Three pre-clinical RCTs (comprising of 198 rats in models of experimental fracture) met the inclusion criteria. These showed that RIC was associated with enhanced callus formation (volume and biomechanical strength) post-fracture, reduced oxidative stress and upregulated osteoblastic activity. Sixteen clinical RCTs, involving 628 patients, investigated RIC in 6 different elective orthopaedic procedures (knee, lower limb, cervical, shoulder, general, hip fracture). RIC protocols varied in cycle frequency, duration, and pressure, but all were given as a single dose at induction of anaesthesia. Significant results included reductions in oxidative stress, improved cerebral and peripheral oxygenation, and reduced pain scores and analgesia use. Only 1 study (n = 648) evaluated RIC in acute hip fracture and demonstrated an early cardioprotective effect.
The potential therapeutic effects of RIC in orthopaedic surgery is supported by preliminary evidence from pre-clinical and clinical studies. Trials to date are largely small but warrant investigation in well-powered multicentre RCTs. There are still many unanswered questions about the optimal RIC parameters (cuff pressure, frequency and duration) in orthopaedic surgery and determining which patients may benefit most from this therapy.
远程缺血预处理(RIC)涉及使用可控的短暂缺血和再灌注循环,通常作用于上肢或下肢,以减轻缺血事件造成的细胞损伤。研究表明,RIC可能具有抗炎和心血管保护作用,因此可能代表一种改善骨科手术后预后的新型治疗策略。本综述旨在全面描述目前RIC在骨科领域的临床前和临床证据。
通过OVID检索MEDLINE和EMBASE(1966年至2024年3月),使用系统检索策略查找调查RIC对骨折、骨愈合和骨科影响的随机对照试验(RCT)。纳入临床前和临床RCT。
三项临床前RCT(包括198只实验性骨折模型大鼠)符合纳入标准。这些研究表明,RIC与骨折后骨痂形成增强(体积和生物力学强度)、氧化应激降低和成骨细胞活性上调有关。16项临床RCT,涉及628例患者,在6种不同的择期骨科手术(膝关节、下肢、颈椎、肩部、普通手术、髋部骨折)中研究了RIC。RIC方案在循环频率、持续时间和压力方面各不相同,但均在麻醉诱导时给予单次剂量。显著结果包括氧化应激降低、脑和外周氧合改善、疼痛评分降低和镇痛药物使用减少。只有1项研究(n = 648)评估了RIC在急性髋部骨折中的作用,并证明了早期心脏保护作用。
临床前和临床研究的初步证据支持RIC在骨科手术中的潜在治疗效果。迄今为止的试验大多规模较小,但值得在大规模多中心RCT中进行研究。关于骨科手术中RIC的最佳参数(袖带压力、频率和持续时间)以及确定哪些患者可能从这种治疗中获益最大,仍有许多未解答的问题。